Voglibose

From WikiMD's Wellness Encyclopedia

(Redirected from Glustat)

Voglibose structure

Voglibose is an antidiabetic drug used for the treatment of type 2 diabetes. It is classified as an alpha-glucosidase inhibitor, which works by delaying the digestion and absorption of carbohydrates from the intestine, leading to a slower and lower rise in blood glucose levels after meals.

Mechanism of Action[edit | edit source]

Voglibose inhibits alpha-glucosidase, an enzyme that breaks down carbohydrates into glucose in the small intestine. By inhibiting this enzyme, voglibose reduces the rate of carbohydrate digestion, resulting in a slower and less pronounced increase in blood glucose levels following meals. This mechanism of action is particularly beneficial for managing postprandial hyperglycemia, a common issue in individuals with type 2 diabetes.

Indications[edit | edit source]

Voglibose is indicated for the management of type 2 diabetes mellitus in adults, particularly for those who are unable to achieve adequate glycemic control with diet and exercise alone. It is often used in combination with other antidiabetic medications, such as metformin or sulfonylureas, to achieve better glycemic control.

Dosage and Administration[edit | edit source]

The dosage of voglibose must be individualized based on the patient's needs and the specific recommendations of a healthcare provider. It is typically taken orally, three times a day, immediately before meals. Starting doses and adjustments should be made according to the patient's blood glucose response, under the guidance of a healthcare professional.

Side Effects[edit | edit source]

Common side effects of voglibose include gastrointestinal symptoms such as flatulence, diarrhea, and abdominal pain. These side effects are usually mild and transient, often diminishing with continued use of the medication. Less commonly, voglibose can cause liver dysfunction and skin reactions. Patients should be monitored for signs of adverse effects and liver function tests should be conducted periodically.

Contraindications[edit | edit source]

Voglibose is contraindicated in patients with known hypersensitivity to the drug, as well as in those with diabetic ketoacidosis or diabetic coma. It should also be used with caution in patients with severe renal impairment or liver disease, as these conditions may affect the drug's metabolism and excretion.

Pharmacokinetics[edit | edit source]

Voglibose is minimally absorbed from the gastrointestinal tract, exerting its effects locally in the intestine. Due to its limited systemic absorption, voglibose has a low potential for systemic side effects and drug interactions. However, its pharmacokinetics can be affected by renal and liver function, necessitating caution in patients with impairment in these organs.

Conclusion[edit | edit source]

Voglibose is an effective medication for managing postprandial blood glucose levels in individuals with type 2 diabetes. Its unique mechanism of action complements other antidiabetic therapies, making it a valuable option for patients who require additional glycemic control. As with any medication, careful consideration of its indications, contraindications, and potential side effects is essential for optimizing treatment outcomes.


WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD